Development of the powder composition with thiosulfonate component and study of its antimicrobial effect
The paper presents the results of research on the development of a potential drug that consists of S-ethyl ester of 4-acetylaminobenzene sulfonic acid and excipients in the powder dosage form for topical use. The powder composition was substantiated on the basis of microbiological studies of the introduced compound and the dosage form based on it. The rational content of the compound as a biologically active substance in the powder was established. The optimal composition of excipients was selected.